Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
XylFII is a periplasmic D-xylose-binding protein that serves as a specialized sensor for environmental xylose in bacteria like Clostridium beijerinckii [1, 18]. It operates as part of a three-component system, interacting with the histidine kinase LytS and the response regulator YesN [1, 24]. The protein consists of two globular domains that bind D-xylose in a central cleft, triggering a transition from an open to a closed conformation [1, 2]. This conformational change promotes the formation of an active heterotetramer with LytS, initiating a signal transduction cascade [1, 18]. The resulting phosphorylation of YesN leads to the induction of the xylFGH operon, which encodes an ABC-type transporter for xylose uptake [1, 24]. XylFII is a primary target for metabolic engineering to enhance the efficiency of xylose fermentation in biofuel production [18, 24]. By modulating the sensing threshold of XylFII, researchers can improve the utilization of lignocellulosic biomass [1, 24]. There are currently no known drugs or therapeutic applications for XylFII in human medicine [1, 18]. Its function is strictly limited to bacterial carbohydrate sensing and metabolic regulation [1, 2]. Understanding its structural dynamics provides insights into how bacteria perceive and respond to nutrient availability in their environment [1, 18].
Not applicable; no drugs are known to target XylFII.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-xylose-binding periplasmic protein (XylFII) (XylFII).